日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer

新辅助帕博利珠单抗联合化疗治疗非转移性三阴性炎性乳腺癌，达到病理完全缓解

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.106050
Lynce, F; Valenza, C; Niman, S M; Bertucci, F; Kai, M; Ryan, S; Troll, E; Layman, R M; Fanucci, K A; Giordano, A; Nasrazadani, A; Nakhlis, F; Bellon, J; Warren, L; Block, C; Schumer, S; Lucci, A; Krishnamurthy, S; Trapani, D; Lerebours, F; Dalenc, F; Levy, C; Petit, T; Leheurteur, M; Bachelot, T; Tredan, O; Ribeiro, J M; Pistilli, B; Zagami, P; Ladoire, S; Lopez Almeida, L; Zemmour, C; Carey, L A; Tolaney, S M; Valero, V; Curigliano, G; Regan, M M; Goncalves, A; Woodward, W A
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doublet.

共同靶向 TGF-β 和 PD-L1 可使三阴性乳腺癌对实验性免疫原性顺铂-艾立布林双药化疗敏感

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI184422
Kalfeist Laura, Ledys Fanny, Petit Stacy, Poirrier Cyriane, Kada Mohammed Samia, Galland Loïck, Derangère Valentin, Ilie Alis, Rageot David, Aucagne Romain, Bellaye Pierre-Simon, Truntzer Caroline, Thibaudin Marion, Rialland Mickaël, Ghiringhelli François, Limagne Emeric, Ladoire Sylvain
免疫/内分泌
乳腺癌
TGF-β
发表日期：2025
文献求助 收藏

PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort

PROMENADE：帕博利珠单抗治疗早期ER低表达/HER2阴性乳腺癌，法国真实世界队列研究

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105907
Cherifi, F; Cabel, L; Bousrih, C; Volant, E; Dalenc, F; Mery, B; Auvray Kuentz, M; Mailliez, A; Ladoire, S; de Nonneville, A; Alexandre, M; Benistant, L; Leheurteur, M; Bailleux, C; Debled, M; Frenel, J-S; Loirat, D; Bastien, E; Aussedat, Q; Bidard, F C; Aho, S; Glenet, A; Mourato-Ribeiro, J; Johnson, A; Christy, F; Emile, G
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib

早期乳腺癌患者接受辅助阿贝西利和/或瑞博西利治疗的患病率、临床病理特征和长期总生存期

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-025-00726-x
Ladoire, Sylvain; Kamga, Ariane Mamguem; Galland, Loick; Reda, Manon; Desmoulins, Isabelle; Mayeur, Didier; Kaderbhai, Courèche; Ilie, Silvia; Hennequin, Audrey; Talucier, Henri; Jankowski, Clementine; Coutant, Charles; Arnould, Laurent; Dabakuyo, Sandrine
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption

探索 ESR1 突变在转移性激素受体阳性乳腺癌 T 细胞免疫监视中断中的作用

期刊:Breast Cancer Research
影响因子:6.1
doi:10.1186/s13058-025-01962-6
Morgane Lopez, Laurie Spehner, Fabrice André, Julien Viot, Evan Seffar, Amélie Marguier, Elsa Curtit, Guillaume Meynard, Erion Dobi, Sylvain Ladoire, Romain Boidot, Romain Loyon, Valentin Derangere, François-Clément Bidard, Christophe Borg, Laura Mansi #, Marie Kroemer #4
免疫
乳腺癌
肿瘤细胞
T Cell Receptor
发表日期：2025
文献求助 收藏

Value of early metabolic response for predicting axillary pathological complete response during neoadjuvant systemic therapy in triple negative and HER2-amplified breast cancers: impact of tumor subtypes

早期代谢反应在预测三阴性及HER2扩增型乳腺癌新辅助全身治疗期间腋窝病理完全缓解中的价值：肿瘤亚型的影响

期刊:Cancer Imaging
影响因子:3.5
doi:10.1186/s40644-025-00914-9
Guichard, Loup; Nunes, Prescillia; Jankowski, Clémentine; Bertaut, Aurélie; Michel, Eloïse; Ladoire, Sylvain; Coutant, Charles; Cochet, Alexandre; Alberini, Jean-Louis
肿瘤
HER2
肿瘤免疫
乳腺癌
代谢
发表日期：2025
文献求助 收藏

Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides

深度学习人工智能通过组织切片预测同源重组缺陷和铂类药物反应

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02641
Bergstrom, Erik N; Abbasi, Ammal; Díaz-Gay, Marcos; Galland, Loïck; Ladoire, Sylvain; Lippman, Scott M; Alexandrov, Ludmil B
发表日期：2024
文献求助 收藏

Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry

基于人群登记研究的数据：真实世界中“高危”早期乳腺癌的患病率、治疗和生存情况，并根据 OlympiA 试验的纳入标准强制进行 gBRCA1/2 突变检测。

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2024.103789
Ladoire, Sylvain; Mamguem Kamga, Ariane; Galland, Loick; Desmoulins, Isabelle; Mayeur, Didier; Kaderbhai, Courèche; Ilie, Silvia Mihaelia; Hennequin, Audrey; Jankowski, Clementine; Albuisson, Juliette; Nambot, Sophie; Coutant, Charles; Arnould, Laurent; Reda, Manon; Truntzer, Caroline; Dabakuyo, Sandrine
BRCA1
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer

基线临床数据、肿瘤代谢和肿瘤血流在预测HER2阳性及三阴性乳腺癌新辅助化疗后病理完全缓解（pCR）中的各自贡献

期刊:Ejnmmi Research
影响因子:3
doi:10.1186/s13550-024-01115-4
Payan, Neree; Presles, Benoit; Coutant, Charles; Desmoulins, Isabelle; Ladoire, Sylvain; Beltjens, Françoise; Brunotte, François; Vrigneaud, Jean-Marc; Cochet, Alexandre
肿瘤
HER2
肿瘤免疫
乳腺癌
代谢
发表日期：2024
文献求助 收藏

Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma

根治性放疗（化疗）与一线手术治疗HPV相关局限性或局部晚期口咽鳞状细胞癌的比较

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0307658
Baude, Jérémy; Guigou, Caroline; Thibouw, David; Vulquin, Noémie; Folia, Mireille; Constantin, Guillaume; Boustani, Jihane; Duvillard, Christian; Ladoire, Sylvain; Truc, Gilles; Bertaut, Aurélie; Chevalier, Cédric
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏